CLINICAL TRIALS AND OBSERVATIONS Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children’s Oncology Group CCG-1952 clinical trial
نویسندگان
چکیده
1Division of Hematology-Oncology, Doernbecher Children’s Hospital/Oregon Health & Science University, Portland; 2Division of Hematology-Oncology, Rainbow Babies & Children’s Hospital, Case Western Reserve University, Cleveland, OH; 3Division of Hematology-Oncology, The Children’s Medical Center/Wright State University Boonshoft School of Medicine, Dayton, OH; 4Children’s Oncology Group, Statistical Office, Arcadia, CA; 5Division of Pediatric Hematology-Oncology, CancerCare Manitoba, Winnipeg, MB; 6Division of Hematology-Oncology, C. S. Mott Children’s Hospital/University of Michigan, Ann Arbor; 7Department of Pathology, Ohio State University, Columbus; 8Clinical Cancer Genetics, City of Hope National Medical Center, Duarte, CA; 9Cancer Institute of New Jersey, University of Medicine and Dentistry of New Jersey, New Brunswick; 10St Charles Medical Center, Bend, OR and Oregon Health & Science University, Portland; and 11Division of Hematology-Oncology, Childrens Hospital Los Angeles, CA
منابع مشابه
Acute lymphoblastic leukemia: an historical perspective.
See the related ASH 50th Anniversary Review articles under the ACUTE AND CHRONIC LEUKEMIAS section of the publication ASH 50th Anniversary Reviews: A Salute to the American Society of Hematology. Astute observations, dedicated researchers, cooperative groups, and clinical trials as well as guinea pig serum, hypoglycemic cows, and periwinkle plant extracts—all contributed to the evolution of the...
متن کاملCLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Prognostic Importance of 6-Mercaptopurine Dose Intensity in Acute Lymphoblastic Leukemia
6-Mercaptopurine (6MP) and methotrexate are the backbone of continuation therapy for childhood acute lymphoblastic leukemia (ALL). In studies of oral 6MP and methotrexate, indices of chronic systemic exposure to active metabolites of these agents, namely, red blood cell (RBC) concentrations of methotrexate polyglutamates (MTXPGs) and thioguanine nucleotides (TGNs) have positively correlated wit...
متن کاملCLINICAL TRIALS AND OBSERVATIONS Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children’s Cancer Group study
We assessed the outcome of children with Down syndrome (DS) and acute lymphoblastic leukemia (ALL) receiving contemporary risk-based therapy by evaluating clinical and biologic features and outcome of children with ALL, with or without DS, enrolled in Children’s Cancer Group (CCG) protocols between 1983 and 1995. Comparison of characteristics of children with ALL with (ALL-DS; n 179) or without...
متن کاملClinical Trials and Observations: Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201
Pediatric Oncology Group (POG) protocol 9201 enrolled children with lesser-risk B-lineage acute lymphoblastic leukemia (ALL) defined by age (1-9), white blood cell count (WBC) less than 50 × 10 (50 000/μL), DNA findings of trisomies 4 and 10 (or DNA index > 1.16), and lack of overt central nervous system (CNS) leukemia. After vincristine, prednisone, and asparaginase induction, 650 of 653 eligi...
متن کاملCLINICAL TRIALS AND OBSERVATIONS Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children’s Oncology Group
We evaluated differences in outcome by ethnicity among children with acute myeloid leukemia (AML). We analyzed 791 children in the CCG 2891 trial and confirmed positive findings in 850 children in the CCG 2961 trial. Hispanic and black children treated with chemotherapy in CCG 2891 had significantly inferior overall survival (OS) from study entry compared with white children (37% 9% vs 48% 4% [...
متن کامل